|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Human EGF (Epidermal Growth Factor) ELISA | Epstein-Barr Virus (EBNA-1) IgM ELISA | Free Prostate Specific Antigen (f-PSA) ELISA | Gd-IgA1 (Galactose-deficient IgA1) ELISA | GLP-1 (Active Form) ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB08073 | IB79860 | IB19127 | 27600 | 27784 |
| Price | Inquire | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Sandwich enzyme-linked immune-sorbent assay (ELISA) for the determination of human EGF concentrations in serum, plasma, cell culture supernatant and other biological samples. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay for the determination of IgM-class antibodies to Epstein-Barr virus nuclear-1 antigen (EBV-EBNA-1) in human serum or plasma. For research use only - not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of f-PSA in human serum. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Solid phase sandwich ELISA for the determination of active form of GLP-1 (GLP-1 (7-36) amide and GLP-1 (7-37)) in EDTA plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | EGF (Epidermal Growth Factor) ELISA | Schistosoma mansoni IgG | PSA (Free) | Metanephrine / Normetanephrine | CMV IgM |
| Sample Type | Human serum, body fluids, tissue homogenate or cell culture supernates. | Serum, Blood Plasma | Serum | Urine | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 3.906 - 250.0 pg/mL | A cut-off control is used for the interpretation of results. | 0.5 to 10.0 ng/mL | 1.56 to 100.0 ng/mL | 1.25 to 80 pmol/L |
| Sensitivity | 2.344 pg/mL | 93.75% (95% confidence interval: 82.8% - 98.69%) | Inquire | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | Inquire |
| Assay Time | 90 min. incubation (37°C) + 60 min. (37°C) + 30 min. (37°C) + 30 min. (37°C) = 3 hours, 30 min. total incubation time | 1 hr 45 mins (incubation) | 1 hr 15 mins (incubation) | 2 hours (incubation) | 2 hrs 30 mins (incubation) |
| Get Quote | Inquire | Supplier Page | Supplier Page | Supplier Page | Supplier Page |